Ray Dalio
BNR

Ray Dalio’s Burning Rock Biotech BNR Stock Holding History

Ray Dalio’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,675
Closed -$36.5K – 749
2023
Q2 		$36.5K Sell
1,675
-4,807
-74% -$128K ﹤0.01% 696
2023
Q1 		$182K Sell
6,482
-2,047
-24% -$61.3K ﹤0.01% 703
2022
Q4 		$192K Sell
8,529
-143
-2% -$3.26K ﹤0.01% 808
2022
Q3 		$207K Sell
8,672
-297
-3% -$9.59K ﹤0.01% 853
2022
Q2 		$261K Sell
8,969
-6,872
-43% -$307K ﹤0.01% 956
2022
Q1 		$1.47M Sell
15,841
-3,519
-18% -$306K 0.01% 743
2021
Q4 		$1.84M Buy
19,360
+3,540
+22% +$485K 0.01% 474
2021
Q3 		$2.83M Buy
15,820
+12,424
+366% +$2.76M 0.02% 379
2021
Q2 		$1M Buy
+3,396
New +$1M 0.01% 586

Other funds holding BNR

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Ray Dalio's BNR Position: Q3 2023 in Review

Ray Dalio sold out of Burning Rock Biotech (BNR) in Q3 2023, closing a stake of 1,675 shares — an estimated $36.5K sold.

Ray Dalio first reported a position in BNR in Q2 2021 and held it in 9 quarters. The position peaked at $2.83M in Q3 2021. 28 funds tracked by Wall St. Rank hold BNR as of Q3 2023.

  • Ray Dalio reported no remaining Burning Rock Biotech position as of Q3 2023 after selling out during the quarter.
  • Ray Dalio sold 1,675 Burning Rock Biotech shares in Q3 2023, an estimated $36.5K.
  • Ray Dalio first reported a position in Burning Rock Biotech in Q2 2021 and held it in 9 quarters.
  • Ray Dalio's Burning Rock Biotech position peaked at $2.83M in Q3 2021.
  • 28 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q3 2023.

Based on Bridgewater Associates's 13F filing for Q3 2023, filed 13 Nov 2023.